These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.
    Author: Manwani D, Frenette PS.
    Journal: Hematology Am Soc Hematol Educ Program; 2013; 2013():362-9. PubMed ID: 24319205.
    Abstract:
    Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin-reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighted the important contributions of various cellular and soluble participants in the vaso-occlusive cascade. The role of these elements and the opportunities for therapeutic intervention are summarized in this review.
    [Abstract] [Full Text] [Related] [New Search]